NPS

Half yearly rpt on consolidated results for the financial period ended 31 Dec 2017

NOVA PHARMA SOLUTIONS BERHAD

Financial Year End 31 Dec 2017
Half Year 2 H
Half yearly report for the financial period ended 31 Dec 2017
The figures have not been audited

Attachments

NOVA HALF YEAR (2H full report) (TA 2) v2.pdf
691.1 kB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
Half Year ended 31 Dec 2017

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR
Half Year
PRECEDING YEAR
CORRESPONDING
Half Year
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31 Dec 2017
31 Dec 2016
31 Dec 2017
31 Dec 2016
$$'000
$$'000
$$'000
$$'000
1 Revenue
3,669
4,056
7,133
7,372
2 Profit/(loss) before tax
1,454
2,176
2,659
2,826
3 Profit/(loss) for the period
1,450
2,172
2,649
2,819
4 Profit/(loss) attributable to ordinary equity holders of the parent
1,450
2,172
2,649
2,819
5 Basic earnings/(loss) per share (Subunit)
0.21
2.17
0.39
2.82
6 Proposed/Declared dividend per share (Subunit)
0.23
0.60
0.26
1.10


AS AT END OF CURRENT
Half Yearly Report
AS AT PRECEDING FINANCIAL YEAR END
7
 Net assets per share attributable to ordinary equity holders of the parent ($$)
0.0500
3.4700

Remarks : 
Note 1 : Basic earnings per share for the current period is computed based on profit for the period divided by weighted average number of shares which are detailed in Note C4 of this interim financial report.

Note 2 : Declared dividend per share is computed based on total dividend declared divided by weighted average number of shares which are detailed in Note C4 of this interim financial report.

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence



Announcement Info

Company Name NOVA PHARMA SOLUTIONS BERHAD
Stock Name NPS
Date Announced 28 Feb 2018
Category Financial Results
Reference Number FRA-28022018-00112


View original report